Abstract
Advances in radiotherapy technology and technique over the last 3 decades have revolutionized radiation treatment options for genitourinary malignancies. The development of more focused and accurate radiation treatment has facilitated safe delivery of dose-escalated treatment that improves disease control and the development of shorter-duration hypofractionated treatment regimens that are more convenient for patients and improve access to treatment. The management of oligometastatic disease is evolving with ablative treatment of oligometastasis and the primary for select patients and shorter-duration palliative treatment regimens. Work is ongoing to personalize radiation treatment regimens for genitourinary malignancies based on molecular biomarkers.
Original language | English (US) |
---|---|
Pages (from-to) | 577-581 |
Number of pages | 5 |
Journal | Urologic Oncology: Seminars and Original Investigations |
Volume | 39 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2021 |
Keywords
- Genitourinary malignancies
- History
- Radiation therapy
ASJC Scopus subject areas
- Oncology
- Urology